Intellectual Property India Publishes Patent Application for Engineered Genetic Construct Compositions For Immune Modulation And Transplant Tolerance

MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202621072026 A) filed by Ansicht Voneden India on June 10, 2026, for Engineered Genetic Construct Compositions For Immune Modulation And Transplant Tolerance.

Inventor includes Dr. Ajinkya Inamdar.

The application for the patent was published on July 31, 2026, under issue no. 31/2026.

Abstract: ABSTRACT ENGINEERED GENETIC CONSTRUCT COMPOSITIONS FOR IMMUNE MODULATION AND TRANSPLANT TOLERANCE The instant disclosure provides engineered immune-modulator construct compositions for localised, targeted, and inflammation-gated suppression of pathological immune activation. A library of sixty-one constructs (SEQ ID NOs: 1 to 61; FIGS. 1 to 61) is organised b...